The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.

A hypoglossal nerve stimulator implant is a device surgically placed inside the body to treat obstructive sleep apnea. Inspire is currently the only brand approved by the Food and Drug Administration ...

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

During its fourth-quarter earnings call this week, Inspire Medical disclosed that it has become the subject of a civil probe ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

If additional information is needed, such as diagnostic or billing ... 2021 Mar;21(5):1784. doi:10.3390/s21051784 Inspire Sleep Apnea Innovation. Frequently asked questions. National Heart, Lung, and ...

We’re proud to offer Inspire upper airway stimulation therapy, a new treatment option for obstructive sleep apnea. Long Island Jewish Medical Center and Glen Cove Hospital are the only hospitals on ...

Obstructive sleep apnea is caused by the collapse of the upper airway during sleep. The muscles supporting soft tissues in the throat relax, narrowing or closing the airway and temporarily ...

Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...

Sleep Apnea Therapy System Market. Key market drivers for Sleep Apnea Therapy System Market include rising prevalence of sleep apnea disorders, growing awa ...